High Throughput News and Research

RSS

Life Technologies completes previously announced acquisition of BioTrove

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has completed the previously announced acquisition of BioTrove, Inc. for an undisclosed amount.

16 Dec 2009

MLL team finds 454 Sequencing technology promising for leukemia genetic characterization

This week at the 51st American Society for Hematology Annual Meeting, a team of researchers from the MLL Munich Leukemia Laboratory presented results from a series of groundbreaking studies which explore alternative, high-throughput 454 Sequencing methods for distinguishing and characterizing the many forms of leukemia and myeloproliferative disorders.

9 Dec 2009

TECHGENE project: CLC bio selected as software partner

Today the EU project, TECHGENE, that focuses on developing Next Generation Sequencing (NGS) diagnostic tools for genetic disorders, announced that CLC bio has been selected as the software partner for this project.

9 Dec 2009

Successful reduction in the levels of aggregated Abeta with GSMs

EnVivo Pharmaceuticals today reported the successful reduction in the levels of aggregated Abeta or Beta-Amyloid in an aged transgenic model (Tg2576) of Alzheimer's disease with its lead gamma-secretase modulator (GSM) EVP-0962. The aggregated Abeta, containing predominately oligomeric and larger Abeta fibrillar species, is considered to be the toxic entity in Alzheimer's disease.

9 Dec 2009

CombinatoRx presents encouraging results from its A2A and b2AR agonist programs for B-cell malignancies

CombinatoRx, Incorporated today announced that preclinical data from its Adenosine A2A receptor (A2A) and Beta-2 Adrenergic Receptor (b2AR) Agonist oncology programs demonstrated synergistic anti-cancer activity when combined with standard-of-care therapies in multiple myeloma and other B-cell malignancies.

8 Dec 2009

TSO3 files medical device amendment for the addition of STERIZONE 125L+ Sterilizer

TSO3 Inc. ("TSO3"), an innovator in low temperature sterilization technology for medical devices in healthcare settings through the use of ozone, today announced that it has filed with Health Canada, a medical device amendment for the addition of the STERIZONE(R) 125L+ Sterilizer to the list of already cleared product for sale in Canada.

8 Dec 2009

NEXUS Biosystems acquires Aurora Biotechnologies

NEXUS Biosystems, Inc. (“Nexus”), a leading innovator and worldwide provider of automated sample management systems, today announced the acquisition of Aurora Biotechnologies of Carlsbad, CA (“Aurora”), a leading developer of proprietary high performance microplates for use in sample storage, high-throughput screening, and cellular imaging.

8 Dec 2009

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.

3 Dec 2009

Researchers build better artificial visual systems using high-performance gaming hardware

Taking inspiration from genetic screening techniques, researchers from Harvard and MIT have demonstrated a way to build better artificial visual systems with the help of low-cost, high-performance gaming hardware.

3 Dec 2009

Guardian Technologies International introduces Signature Mapping TBDx to diagnose TB

Guardian Technologies International is bringing the diagnosis of tuberculosis (TB) into the 21st century with Signature Mapping TBDx™ (SM TBDx), an automated diagnostic solution using sophisticated detection algorithms to identify TB under microscopy in sputum samples, at the laboratory level.

2 Dec 2009

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

The Cancer Genomic Microarray Facility at the Kimmel Cancer Center of the Thomas Jefferson University, Philadelphia, selected febit's Geniom® RT Analyzer to advance its biomedical research by proceeding targeted Next-Generation Sequencing (NGS), genome-wide single nucleotide polymorphism (SNP) and microRNA (miRNA) analysis.

2 Dec 2009

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

Trellis Bioscience, Inc. announced today the granting of a worldwide exclusive license to MedImmune, LLC, the global biologics unit of AstraZeneca, to develop and commercialize Trellis’ antibodies directed against the respiratory syncytial virus (RSV).

1 Dec 2009

Genetic Analysis introduces GA-map microarray test for screening of infant gut microbiota

Genetic Analysis AS, the molecular diagnostics company, has launched its GA-map™ microarray test for high throughput screening of infant gut microbiota. At the recent Sackler Colloquium on Microbes and Health in the US, the company presented data from evaluation screens that show its potential as a tool for probing the mechanisms of disease in conditions associated with the gut flora.

1 Dec 2009

Exiqon announces the recognition of ICCB-L

Exiqon A/S announced today that the Harvard Medical School ICCB-Longwood Screening Facility (ICCB-L) has been recognized as a MicroRNA Screening Center of Excellence.

30 Nov 2009

Siemens Healthcare to showcase latest medical imaging technologies at RSNA 2009

At the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), "Images, my way" will resonate throughout the Siemens Healthcare booth (#825) from November 29 to December 3 at McCormick Place (Booth #825, East Building/Lakeside Center, Hall D) in Chicago.

30 Nov 2009

New technology developed to rapidly identify compounds for the treatment of heart failure

Research conducted by University of Minnesota scientists, in collaboration with Celladon Corporation, has led to the invention of technology to more rapidly identify compounds for the treatment of heart failure.

24 Nov 2009

EraGen Biosciences to have access to Illumina’s BeadXpress platform

EraGen Biosciences Inc., a developer of novel molecular reagents for the in-vitro diagnostics (IVD) market, and Illumina Inc., a global company that develops, manufactures and markets integrated systems for analysis of genetic variation and biological function, today announced the formation of a strategic partnership and the execution of non-exclusive licensing agreements.

From Illumina, Inc. 23 Nov 2009

Johns Hopkins University to create a Human Proteome Chip using Arrayit's technology

Arrayit Corporation announced today that the new High Throughput Biology Center at Johns Hopkins University School of Medicine in Baltimore Maryland purchased Arrayit's proprietary technology to create a Human Proteome Chip to discover biomarkers for autoimmune diseases including rheumatoid arthritis, inflammatory bowel disease, autoimmune hepatitis (first identified by Dr. Zhu), lupus, and others.

18 Nov 2009

Asterand to acquire BioSeek

Asterand plc (LSE: ATD), a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announces it has signed an agreement to acquire BioSeek Inc.

18 Nov 2009

Life Technologies to acquire BioTrove

Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire BioTrove, Inc. for an undisclosed amount.

10 Nov 2009

High Throughput News and Research

Life Technologies completes previously announced acquisition of BioTrove

MLL team finds 454 Sequencing technology promising for leukemia genetic characterization

TECHGENE project: CLC bio selected as software partner

Successful reduction in the levels of aggregated Abeta with GSMs

CombinatoRx presents encouraging results from its A2A and b2AR agonist programs for B-cell malignancies

TSO3 files medical device amendment for the addition of STERIZONE 125L+ Sterilizer

NEXUS Biosystems acquires Aurora Biotechnologies

CLC bio, imaGenes announce collaboration in high-throughput sequencing analyses

Researchers build better artificial visual systems using high-performance gaming hardware

Guardian Technologies International introduces Signature Mapping TBDx to diagnose TB

Cancer Genomic Microarray Facility selects febit's Geniom RT Analyzer to advance its biomedical research

MedImmune to develop and commercialize Trellis Bioscience's anti-RSV antibodies

Genetic Analysis introduces GA-map microarray test for screening of infant gut microbiota

Exiqon announces the recognition of ICCB-L

Siemens Healthcare to showcase latest medical imaging technologies at RSNA 2009

New technology developed to rapidly identify compounds for the treatment of heart failure

EraGen Biosciences to have access to Illumina’s BeadXpress platform

Johns Hopkins University to create a Human Proteome Chip using Arrayit's technology

Asterand to acquire BioSeek

Life Technologies to acquire BioTrove

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News